0001127602-20-019506.txt : 20200612 0001127602-20-019506.hdr.sgml : 20200612 20200612170242 ACCESSION NUMBER: 0001127602-20-019506 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200611 FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 20960955 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-06-11 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 1 Chairman & CEO Common Stock 2020-06-11 4 M 0 10000 63.22 A 10140 D Common Stock 2020-06-11 4 S 0 2765 116.3774 D 7375 D Common Stock 2020-06-11 4 S 0 2443 117.5702 D 4932 D Common Stock 2020-06-11 4 S 0 1875 118.627 D 3057 D Common Stock 2020-06-11 4 S 0 2723 119.5462 D 334 D Common Stock 2020-06-11 4 S 0 194 120.334 D 140 D Common Stock 2020-06-12 4 M 0 10000 63.22 A 10140 D Common Stock 2020-06-12 4 S 0 1643 114.4116 D 8497 D Common Stock 2020-06-12 4 S 0 5565 115.1946 D 2932 D Common Stock 2020-06-12 4 S 0 579 116.0656 D 2353 D Common Stock 2020-06-12 4 S 0 1489 117.6081 D 864 D Common Stock 2020-06-12 4 S 0 724 118.1498 D 140 D Common Stock 166 I By Spouse Common Stock 663879 I By Trusts Stock Options 63.22 2020-06-11 4 M 0 10000 0 D 2010-12-31 2020-12-31 Common Stock 10000 184834 D Stock Options 63.22 2020-06-12 4 M 0 10000 0 D 2010-12-31 2020-12-31 Common Stock 10000 174834 D This exercise of options and sale of options is pursuant to a prearranged 10b5-1 trading plan. The trading plan contemplates the exercise and sale of up to 364,834 options with an exercise price of $63.22/share, which were granted in December 2010 and are set to expire at the end of 2020. Assuming relevant conditions are met, this tranche of options will be exercised in daily installments of 10,000 shares during May-July, 2020. This transaction was executed in multiple trades at prices ranging from $115.925 to $116.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $117.05 to $118.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $118.08 to $119.075. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $119.12 to $120.095. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $120.20 to $120.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $113.75 to $114.735. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $114.75 to $115.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $115.785 to $116.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $116.97 to $117.965. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $117.97 to $118.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2020-06-11